Esperion Raises $189.9 Million On Wall Street: Investors Take Profits
ANN ARBOR ? Esperion Therapeutics raised another $189.9 million in a stock offering Tuesday afternoon and investors unloaded shares Wednesday to take profits driving the share price down by 15 percent at the closing bell. Considering that Esperion?s year-to-date return is a whopping 154 percent, at a time when the broader biotech industry retreats, it?s